2047-2900/asset/olbannerleft.gif?v=1&s=96b96c0a069a6c9c26d75997a6fa5880d8f5251a)
2047-2900/asset/olbannerright.gif?v=1&s=95c198b5faf64f58a9da1b3f9c3ab4c26ee56f67)
Debate
Why I would encourage my wife to take HRT if she had type 2 diabetes
Article first published online: 29 AUG 2000
DOI: 10.1002/1528-252X(200007/08)17:5<161::AID-PDI88>3.0.CO;2-2
Copyright © 2000 John Wiley & Sons, Ltd.
1528-252X/asset/cover.gif?v=1&s=07ac565565542447cf1ca944ad7c464aa2472aeb "Practical Diabetes International")
Additional Information
How to Cite
Gill, G. (2000), Why I would encourage my wife to take HRT if she had type 2 diabetes. Practical Diabetes International, 17: 161–162. doi: 10.1002/1528-252X(200007/08)17:5<161::AID-PDI88>3.0.CO;2-2
Publication History
- Issue published online: 29 AUG 2000
- Article first published online: 29 AUG 2000
- Manuscript Accepted: 17 APR 2000
- Manuscript Received: 15 FEB 2000
- Abstract
- Article
- References
- Cited By
Keywords:
- diabetes mellitus;
- type 2 diabetes;
- menopause;
- HRT;
- coronary artery disease
Abstract
Post‒menopausal type 2 diabetic patients are at enormous risk of increased mortality and morbidity from coronary artery disease (CAD). Attempts to modify contributory risk factors are likely to be only partially successful, and any other beneficial strategy should be vigorously adopted. Such a potential strategy is hormone (oestrogen) replacement therapy (HRT). Though a prospective randomised controlled trial of HRT for CAD primary prevention in type 2 diabetic females is lacking, there is considerable supportive evidence for its use, particularly of modern preparations. HRT should be seriously considered as a preventive strategy in this very high risk group of patients. Copyright © 2000 John Wiley & Sons, Ltd.